1.20 (-%)
As of Nov 01, 2024
Source:
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (“MCr”) system.
| Country | United States |
| Headquarters | cranbury, new jersey |
| Phone Number | 609-495-2200 |
| Industry | manufacturing |
| CEO | Carl Spana |
| Website | www.palatin.com |